AccuStem Sciences, Inc.
ACUT
$0.276
-$0.0193-6.54%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 156.50K | 578.60K | 358.20K | 817.70K | 845.40K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 246.00K | 598.50K | 372.80K | 833.30K | 978.50K |
| Operating Income | -246.00K | -598.50K | -372.80K | -833.30K | -978.50K |
| Income Before Tax | -246.00K | -598.50K | -372.80K | -833.30K | -978.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -246.00K | -598.50K | -372.80K | -833.30K | -978.50K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -246.00K | -598.50K | -372.80K | -833.30K | -978.50K |
| EBIT | -246.00K | -598.50K | -372.80K | -833.30K | -978.50K |
| EBITDA | -245.10K | -597.60K | -371.80K | -832.40K | -977.60K |
| EPS Basic | -0.02 | -0.05 | -0.03 | -0.07 | -0.09 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.02 | -0.05 | -0.05 |
| EPS Diluted | -0.02 | -0.05 | -0.03 | -0.07 | -0.09 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.02 | -0.05 | -0.05 |
| Average Basic Shares Outstanding | 11.35M | 11.35M | 11.35M | 11.35M | 11.35M |
| Average Diluted Shares Outstanding | 11.35M | 11.35M | 11.35M | 11.35M | 11.35M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
